Author

E. Mendelson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:host-pathogen & immune response· 3 Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

M. Mandelboim· 3 shared J. Jacob-Hirsch· 2 shared N. Friedman· 2 shared Y. Drori· 2 shared A. Glatman-Freedman· 1 shared A. Mechaly· 1 shared A. Tennenhouse· 1 shared A. Zvi· 1 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

M. Mandelboim

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against novel viral variants

E. Makdasi, A. Zvi, R. Alcalay, T. Noy-Porat, E. Peretz, A. Mechaly, Y. Levy, E. Epstein, T. Chitlaru, A. Tennenhouse, M. Aftalion, D. Gur, N. Paran, H. Tamir, O. Zimhony, , R. Rosenfeld

This study evaluates the neutralization potency of four SARS-CoV-2 mAbs against spike mutations and two variants of concern, finding that MD65 and BL6 retain effectiveness against B.1.1.7 and B.1.351.

bioRxiv · Apr 1, 2021Immunology

Transcriptomic profiling of human corona virus (HCoV)-229E -infected human cells and genomic mutational analysis of HCoV-229E and SARS-CoV-2

N. Friedman, J. Jacob-Hirsch, Y. Drori, E. Eyal, N. Kol, O. Nayshool, E. Mendelson, G. Rechavi, M. Mandelboim

This study uses transcriptomic analysis to identify cellular pathway changes in HCoV-229E-infected cells and links APOBEC3B activity to genomic mutations in SARS-CoV-2.

bioRxiv · Aug 17, 2020Microbiology

Influenza virus inhibits respiratory syncytial virus (RSV) infection via a two-wave expression of interferon-induced protein with tetratricopeptide (IFIT) proteins

Y. Drori, J. Jacob-Hirsch, R. Pando, A. Glatman-Freedman, N. Friedman, E. Mendelson, M. Mandelboim

This study shows influenza virus inhibits RSV infection through a two-wave upregulation of IFIT proteins, observed in both in vitro and in vivo models.

bioRxiv · Aug 17, 2020Microbiology